MACULAR DEGENERATION
Clinical trials for MACULAR DEGENERATION explained in plain language.
Never miss a new study
Get alerted when new MACULAR DEGENERATION trials appear
Sign up with your email to follow new studies for MACULAR DEGENERATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New eye implant could reduce need for frequent shots in wet AMD
Disease control OngoingThis study tests a new medicine called zifibancimig for people with wet age-related macular degeneration (nAMD), a leading cause of vision loss. The treatment is given as an eye injection or through a small implant that releases the drug over time. The goal is to see if it is saf…
Matched conditions: MACULAR DEGENERATION
Phase: PHASE1, PHASE2 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated May 17, 2026 03:59 UTC
-
New eye drug aims to slow vision loss from dry macular degeneration
Disease control OngoingThis study tests an experimental drug called AVD-104, given as an eye injection, in 300 people with geographic atrophy (a late stage of dry age-related macular degeneration). The goal is to see if it is safe and can slow the growth of damaged areas in the retina, helping to preve…
Matched conditions: MACULAR DEGENERATION
Phase: PHASE2 • Sponsor: Aviceda Therapeutics, Inc. • Aim: Disease control
Last updated May 17, 2026 03:59 UTC
-
Healthy eyes, big insights: new study could pave way for vision loss therapies
Knowledge-focused OngoingThis study looks at how the brain changes and adapts when the central part of vision is lost, which happens in conditions like macular degeneration. Researchers will test healthy adults aged 18-30 with normal vision to understand these brain changes better. The goal is to use thi…
Matched conditions: MACULAR DEGENERATION
Phase: NA • Sponsor: University of Alabama at Birmingham • Aim: Knowledge-focused
Last updated May 17, 2026 03:55 UTC